Covance Becomes SCRS Global Impact Partner
The Society for Clinical Research Sites (SCRS) announced a two-year partnership with LabCorp.
The Society for Clinical Research Sites (SCRS) announced a two-year partnership with LabCorp. Under the agreement, Covance will participate as a Global Impact Partner (GIP), a relationship designed to facilitate dialogue between industry stakeholders and clinical research sites. As a GIP, Covance will participate on the SCRS Global Impact Board at an executive level, and work in tandem with SCRS’ Leadership Council in the development and execution of strategic initiatives for SCRS.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
